These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4123332)

  • 21. Letter: E-rosette formation specific for T lymphocytes.
    Farid NR; Row VV; Volpé R
    N Engl J Med; 1974 Apr; 290(17):970. PubMed ID: 4544653
    [No Abstract]   [Full Text] [Related]  

  • 22. Thyrotrophin receptor-specific memory T cell responses require normal B cells in a murine model of Graves' disease.
    Pichurin P; Aliesky H; Chen CR; Nagayama Y; Rapoport B; McLachlan SM
    Clin Exp Immunol; 2003 Dec; 134(3):396-402. PubMed ID: 14632743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral T and B lymphocytes do not correlate with Graves' orbitopathy.
    Ionni I; Rotondo Dottore G; Marinò M
    J Endocrinol Invest; 2018 Nov; 41(11):1355-1356. PubMed ID: 30182361
    [No Abstract]   [Full Text] [Related]  

  • 24. Peripheral blood B-lymphocyte abnormalities associated with hyperthyroidism of Graves' disease.
    Hsu CC; Chen Y; Patterson R
    Clin Exp Immunol; 1976 Dec; 26(3):431-40. PubMed ID: 64326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase of T cells in Graves' disease.
    Farid NR; Von Westarp C; Row VV; Volpe R
    Lancet; 1973 Jul; 2(7822):204-5. PubMed ID: 4124280
    [No Abstract]   [Full Text] [Related]  

  • 26. Subpopulations of intrathyroidal lymphocytes in Graves' disease.
    Duh YC; Su IJ; Liaw KY; Yao CC
    J Formos Med Assoc; 1990 Feb; 89(2):121-5. PubMed ID: 1973719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of lymphoid cells in the thyroid of patients with Graves' disease.
    Warford A; McLachlan SM; Malcolm AJ; Young ET; Farndon JR; Rees Smith B
    Clin Exp Immunol; 1984 Sep; 57(3):626-32. PubMed ID: 6235996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-mediated immunity in thyroid disease.
    Farid NR; Munro RE; Row VV; Volpé R
    Br Med J; 1973 Mar; 1(5854):677. PubMed ID: 4540302
    [No Abstract]   [Full Text] [Related]  

  • 29. [Peripheral distribution of lymphocyte subpopulations in Basedow's disease. Decrease in suppressor T-lymphocytes].
    Edan G; Genetet N; Le Reun M; Hespel JP; Genetet B; Simon M
    Presse Med; 1983 Feb; 12(9):557-60. PubMed ID: 6219370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal B lymphocyte function in thyroid glands from patients with Graves' disease.
    Ueki Y; Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Tezuka H; Nakao H; Kawakami A; Migita K; Ishikawa
    J Clin Endocrinol Metab; 1989 Nov; 69(5):939-45. PubMed ID: 2793996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [T-cells and B-cells in the peripheral blood in Basedow's disease and Hashimoto's disease].
    Oshima K; Inazawa M; Awashima S; Katakai S; Ozawa K
    Horumon To Rinsho; 1978 Jan; 26(1):25-9. PubMed ID: 308417
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter: Proportion of E rosettes normal in Graves's and Hashimoto's disease: a retraction.
    Volpé R; Row VV
    N Engl J Med; 1975 Jul; 293(1):44. PubMed ID: 1079321
    [No Abstract]   [Full Text] [Related]  

  • 33. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease.
    Mori H; Amino N; Iwatani Y; Asari S; Izumiguchi Y; Kumahara Y; Miyai K
    J Clin Endocrinol Metab; 1982 Sep; 55(3):399-402. PubMed ID: 6178751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated T cells in Graves' disease before treatment.
    Kennedy R; Di Mario U; Pozzilli P; Guy K; Leonardi M; Sensi M; Andreani D
    Clin Exp Immunol; 1985 Feb; 59(2):377-82. PubMed ID: 3156702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.
    Nagata K; Hara S; Nakayama Y; Higaki K; Sugihara H; Kuwamoto S; Matsushita M; Kato M; Tanio S; Ishiguro K; Hayashi K
    Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different immunophenotype and autoantibody production by peripheral blood and thyroid-derived lymphocytes in patients with Graves' disease.
    Aust G; Lehmann I; Heberling HJ
    Exp Clin Endocrinol Diabetes; 1996; 104(1):50-8. PubMed ID: 8750571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased activated T-lymphocytes and normal thyrotropin receptor antibody levels in Graves' disease in long-term remission.
    Peakman M; Hussain M; Cundy T; Vergani D
    J Clin Lab Immunol; 1989 Sep; 30(1):1-5. PubMed ID: 2577115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy.
    Weetman AP; Cohen S; Gatter KC; Fells P; Shine B
    Clin Exp Immunol; 1989 Feb; 75(2):222-7. PubMed ID: 2784734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T and B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy.
    Weetman AP; Fells P; Shine B
    Br J Ophthalmol; 1989 May; 73(5):323-7. PubMed ID: 2786428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressor T lymphocyte dysfunction in Graves' disease: role of the H-2 histamine receptor-bearing suppressor T lymphocytes.
    Okita N; How J; Topliss D; Lewis M; Row VV; Volpé R
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1002-7. PubMed ID: 7026590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.